ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women
- PMID: 39495342
- PMCID: PMC11707217
- DOI: 10.1007/s10815-024-03299-z
ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women
Abstract
Purpose: To assess oocyte competence and embryo chromosomal constitution in phenotype-D PCOS women undergoing ICSI for PGT-A at the blastocyst stage.
Methods: Retrospective study at a private IVF center. In the period 2013-2021, 58 naïve phenotype-D PCOS women (i.e., oligomenorrhea, ovarian PCO-morphology, and absence of hyperandrogenism) underwent ICSI with ejaculated sperm for PGT-A. These cases were matched to 58 controls selected from 2211 naïve women with idiopathic infertility planned for the same treatment in the same period. The matching variables were age (≈ 36 years), BMI (≈ 22), cumulus oocyte complexes (COCs) retrieved (≈ 21-23), and sperm quality (≈ 43-45% men with all sperm parameters > 5th percentile). The primary outcome was euploid blastocyst rate (EBR) per cohort of inseminated oocytes.
Results: Maturation rates per COCs and euploidy per biopsied blastocysts were similar. PCOS patients with phenotype-D showed higher fertilization per inseminated oocytes and higher blastulation per zygotes. This resulted into a higher EBR per inseminated oocytes and more euploid blastocysts available for transfer, although these differences adjusted for confounders were not significant. The live birth rate per first euploid transfers was comparable, so were all other outcomes considered.
Conclusions: Oocyte competence was not compromised in phenotype-D PCOS women, while good prognosis idiopathic infertile women might have unknown oocyte issues. In case of repeated failures after intrauterine insemination, a timely referral to IVF might represent an efficient strategy, in line with the "one-and-done" approach fulfilling a family planning perspective. Indeed, 22% of the phenotype-D PCOS women had 2 singleton LBs and 76% had surplus oocytes/euploid blastocysts after achieving ≥ 1 live birth.
Keywords: Blastocyst; Euploid; Oocyte competence; PCOS phenotype-D; PGT-A.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Similar articles
-
[Study of the feasibility of polar body transfer combined with preimplantation genetic testing for blocking the intergenerational transmission of mitochondrial genetic diseases].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025 Jan 10;42(1):18-25. doi: 10.3760/cma.j.cn511374-20240702-00366. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025. PMID: 39779332 Chinese.
-
Multi-omics PGT: re-evaluation of euploid blastocysts for implantation potential based on RNA sequencing.Hum Reprod. 2024 Dec 1;39(12):2861-2872. doi: 10.1093/humrep/deae237. Hum Reprod. 2024. PMID: 39413437 Free PMC article.
-
Pretreatment with oral contraceptive pills in women with PCOS scheduled for IVF: a randomized clinical trial.Hum Reprod Open. 2024 Apr 4;2024(2):hoae019. doi: 10.1093/hropen/hoae019. eCollection 2024. Hum Reprod Open. 2024. PMID: 39697220 Free PMC article.
-
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD012693. doi: 10.1002/14651858.CD012693.pub3. Cochrane Database Syst Rev. 2024. PMID: 38174816 Free PMC article. Review.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.
References
-
- Abraham Gnanadass S, Divakar Prabhu Y, Valsala GA. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303:631–43. - PubMed
-
- Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189:G43–64. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical